Plant extract companies in China are seeing more demand for immune-related raw materials, but most are adopting a cautious stance when it comes to capacity building due to trade uncertainties brought on by COVID-19.
China’s State Administration for Market Regulation (SAMR) is encouraging health food firms to contribute to the expansion of the Health Food Raw Materials Directory by presenting evidence to support the functional efficacy of ingredients to the unit.
Pure plant matter should be prioritised over botanical extracts if herbal supplement makers hope to achieve longevity in the industry, according to one industry player which is seeing its wholly plant-based supplements business soar